Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Helen Knight

People with blood cancer to benefit from innovative new treatment on the NHS

The type of Car T-cell therapy involves taking a patient’s T-cells and modifying them.

Evening Standard · Feb 20, 2025

Daily pill on NHS offers new hope for hundreds with lung cancer

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery

The Independent UK · Jan 21, 2025

Daily pill for lung cancer to be made routinely available on the NHS

According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific mutations.

The Independent UK · Jan 21, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

NHS to get drug which helps prevent hearing loss in children having chemotherapy

Around 60 children and young people each year will benefit from Pedmarqsi.

The Independent UK · Dec 20, 2024

Daily tablet for advanced breast cancer patients set for NHS rollout

Elacestrant is recommended for patients whose cancer has worsened after at least a year of treatment with hormone therapy and CDK4/6 inhibitor.

The Independent UK · Dec 19, 2024

Hundreds of blood cancer patients to benefit from new treatment

Elranatamab, an injection that treats myeloma, has been recommended for NHS use by the National Institute for Health and Care Excellence.

Evening Standard · Oct 29, 2024

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

Donanemab is a so-called disease-modifying treatment.

Evening Standard · Oct 23, 2024

Read news from The Economist, FT, and more,
with one subscription

Patients in England to be offered daily pill that can halve migraine frequency

Nice approves first oral treatment with Atogepant that can prevent chronic and episodic migraines

The Guardian - UK · Apr 11, 2024

Groundbreaking migraine treatment offers ‘new hope’ for patients

‘It will especially benefit those who have not found a treatment that works’

The Independent UK · Sep 14, 2023

Hope for thousands as NHS approves drug for acute migraine

First and only Nice-recommended medicine could ‘alleviate misery’ of condition in England and Wales

The Guardian - UK · Sep 13, 2023

Migraine treatment ‘brings new hope’ for those with condition

The soluble wafer stops the release of a protein around the brain.

The Independent UK · Sep 13, 2023

Another weight loss jab approved for NHS use

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK · Sep 8, 2023

Weight loss jab recommended to treat type 2 diabetes

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK · Sep 7, 2023

More info needed on weight-loss jab’s impact on type 2 diabetes – Nice

The once-weekly jab would be offered to diabetic patients alongside diet and exercise,

The Independent UK · Jun 26, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Jun 2, 2023

New drug could help thousands with chronic heart disease in England

Nice approves mavacamten, used to treat obstructive hypertrophic cardiomyopathy, in draft guidance to NHS

The Independent UK · Jun 2, 2023

Innovative heart condition drug recommended for NHS patients

Mavacamten would be used to treat obstructive hypertrophic cardiomyopathy, with about 7,000 people expected to benefit.

Daily Mirror · May 31, 2023

Thousands of Brits with excruciating migraines to get first ever targeted drug

A first-ever dedicated oral treatment for migraines is to be offered on the NHS for more than six million people suffering from excruciating headaches after the drug Rimegepant was approved

Daily Record · Apr 25, 2023

Hero Scots dad saves elderly woman and her daughter from horror house fire

Dean Clark was on his way to work on Monday, April 24, when he saw smoke pouring into the sky from a nearby property.

Get all your
news in one place.

100's of premium titles.
One news app.

Edinburgh Live · Apr 24, 2023

Heroic father-of-four saves Edinburgh gran and daughter from burning inferno

Dean Clark's actions are said to have potentially saved the lives of two Niddrie family members who found themselves trapped inside a burning bungalow in the early hours of Monday morning.

The Independent UK · Jul 13, 2022

New breast cancer drugs to benefit thousands

Two drugs are being made available to patients through the cancer drugs fund.

Daily Mirror · Jun 17, 2022

Thousands of women with breast cancer could benefit from new NHS-approved pill

A clinical trial found that people taking the drug alongside hormone therapy had a more than 30% better chance of their cancer not coming back

The Guardian - UK · Jun 17, 2022

NHS to offer women in England drug that cuts recurrence of breast cancer

Abemaciclib can improve chances of certain type of cancer not returning after surgery by more than 30%

The Independent UK · Jun 16, 2022

About 4,000 women with breast cancer could benefit from new twice-daily pill

The drug, made by Eli Lilly, is suitable for those with hormone receptor-positive, HER2-negative, node-positive early breast cancer.

The Independent UK · May 25, 2022

New hope for women with advanced breast cancer as immunotherapy drug approved for NHS

Keytruda is for women with incurable secondary triple negative breast cancer and its aim is to slow disease progression.

The Independent UK · May 24, 2022

Women with advanced breast cancer get new immunotherapy on the NHS

Keytruda is for women with incurable secondary triple negative breast cancer and its aim is to slow disease progression.

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

the National Institute for Health and Care Excellence

30 stories

National Institute for Health and Care Excellence

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.